Stock Information

• Allogene Therapeutics Announces Nature Communications Publication Highlighting Pre-Clinical Data for ALLO-329, a Next Generation Dual-Targeted CD19/CD70 Allogeneic CAR T for Autoimmune Diseases
  Wed, Apr 15, 2026 8:30 AM
• Allogene Therapeutics announces pricing of public offering of common stock
  Tue, Apr 14, 2026 9:54 PM
• 12 Health Care Stocks Moving In Tuesday's Intraday Session
  Tue, Apr 14, 2026 1:05 PM
• Bernstein Maintains Market Perform on Allogene Therapeutics, Raises Price Target to $3.85
  Tue, Apr 14, 2026 11:42 AM
• Argus Research Maintains Market Perform on Allogene Therapeutics, Raises Price Target to $3.85
  Tue, Apr 14, 2026 11:37 AM
• Citizens Maintains Market Outperform on Allogene Therapeutics, Raises Price Target to $8
  Tue, Apr 14, 2026 8:27 AM
• JPMorgan, Allogene Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
  Tue, Apr 14, 2026 8:02 AM
• Apple To Rally More Than 25%? Here Are 10 Top Analyst Forecasts For Tuesday
  Tue, Apr 14, 2026 7:54 AM
• Baird Maintains Outperform on Allogene Therapeutics, Raises Price Target to $9
  Tue, Apr 14, 2026 7:48 AM
• HC Wainwright & Co. Maintains Buy on Allogene Therapeutics, Raises Price Target to $12
  Tue, Apr 14, 2026 7:07 AM

Financial data not available